<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01977040</url>
  </required_header>
  <id_info>
    <org_study_id>OBX0025</org_study_id>
    <nct_id>NCT01977040</nct_id>
  </id_info>
  <brief_title>Optimal Management of Vasa Previa Study - A Retrospective Study</brief_title>
  <acronym>VasaPrevia</acronym>
  <official_title>Optimal Management of Vasa Previa: Screening, Diagnosis and Management - A Retrospective Study.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Obstetrix Medical Group</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mednax Center for Research, Education, Quality and Safety</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a multicenter retrospective observational study of women diagnosed with a vasa previa
      during pregnancy or at delivery who delivered between 2000 and 2012. The study hopes to be
      able to describe techniques utilized to screen for and diagnose vasa previa as well as to
      describe the maternal characteristics and identify potential underlying risk factors that may
      provide a basis for future screening recommendations for vasa previa and treatment protocols.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a multicenter retrospective study of women identified as having a vasa previa during
      pregnancy or at the time of delivery who delivered between January 1, 2000 and December 31,
      2012 at participating centers. The primary objective of the study is to describe techniques
      utilized to screen for and diagnose vasa previa.

        -  In those cases that were diagnosed antenatally, to describe the different management
           protocols utilized, correlate these management protocols with neonatal outcomes and
           support the management protocol that offers optimal outcomes for both mother and
           neonate.

        -  In those cases that were not diagnosed antenatally, to describe the clinical scenario
           surrounding delivery and the neonatal outcomes. Review the ultrasound reports and
           maternal characteristics to identify any potential risk factors for vasa previa that
           could have been identified antenatally in attempt to improve neonatal outcomes in the
           future.

        -  In all cases of diagnosed vasa previa (those diagnosed antepartum, intrapartum, and
           postpartum), to describe the maternal characteristics and identify potential underlying
           risk factors that may provide a basis for future screening recommendations and
           protocols. Due to the rarity of this diagnosis, the study hopes to include 100-250
           participants.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2014</start_date>
  <completion_date type="Actual">January 2015</completion_date>
  <primary_completion_date type="Actual">January 2015</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Diagnostic Profile of Techniques Utilized to Screen for and Diagnose Vasa Previa During Pregnancy.</measure>
    <time_frame>Participants will be followed from time of diagnosis of vasa previa until the baby is born, an expected time frame of 9 months</time_frame>
    <description>The primary outcome of the study it to describe antenatal techniques utilized to screen for and diagnose vasa previa. Vasa previa is when unprotected blood vessels implanted in the membranes or sac run from the placenta across the inside of the woman's cervix. Antepartum ultrasounds were conducted according to standard of care. Here we report the count of participants who were diagnosed during routine ultrasound exam. After initial diagnosis by ultrasound, Vasa Previa's were followed up by routine ultrasounds for confirmation prior to delivery.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Gestational Age at Time of Diagnosis Stratified by Diagnostic Profile.</measure>
    <time_frame>Participants will be followed from time of diagnosis of vasa previa during the second trimester up until delivery.</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Mode of Delivery Stratified by Diagnostic Profile.</measure>
    <time_frame>At birth.</time_frame>
    <description>Mode of delivery (C/S - emergent, non-emergent, vaginal) stratified by diagnostic profile</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Gestational Age of Infant at Birth</measure>
    <time_frame>At birth.</time_frame>
    <description>Gestational age of the infant noted in weeks at the time of birth</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">68</enrollment>
  <condition>Vasa Previa</condition>
  <arm_group>
    <arm_group_label>Vasa Previa</arm_group_label>
    <description>Women with the diagnosis of Vasa Previa made during the pregnancy or at time of delivery who delivered between January 1, 2000 and December 31, 2012.</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Women at participating site who have been identified as having a vasa previa between
        January 1, 2000 and December 31, 2012.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with the diagnosed of vasa previa made either during the pregnancy via
             ultrasound or at time of delivery via clinical and/or pathologic investigation.

          -  Patient delivered between January 2000 through December 2012

        Exclusion Criteria:

          -  No diagnosis or confirmation of vasa previa

          -  Delivered either before January 1, 2000 or after December 31, 2012
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Thomas Garite, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Pediatrix Medical Group, Inc.</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of South Alabama Medical Center</name>
      <address>
        <city>Mobile</city>
        <state>Alabama</state>
        <zip>36617</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Banner Desert Medical Center</name>
      <address>
        <city>Mesa</city>
        <state>Arizona</state>
        <zip>85210</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Banner Good Samaritan Medical Center</name>
      <address>
        <city>Phoenix</city>
        <state>Arizona</state>
        <zip>85006</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Saddleback Memorial Medical Center</name>
      <address>
        <city>Laguna Hills</city>
        <state>California</state>
        <zip>92653</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Long Beach Memorial Medical Center</name>
      <address>
        <city>Long Beach</city>
        <state>California</state>
        <zip>90801-1428</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Good Samaritan Hospital</name>
      <address>
        <city>San Jose</city>
        <state>California</state>
        <zip>95008</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Presbyterian/St Luke's Hospital</name>
      <address>
        <city>Denver</city>
        <state>Colorado</state>
        <zip>80218</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Saint Luke's Hospital, Kansas City</name>
      <address>
        <city>Kansas City</city>
        <state>Missouri</state>
        <zip>64111</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Swedish Medical Center</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98122-4307</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2019</verification_date>
  <study_first_submitted>October 4, 2013</study_first_submitted>
  <study_first_submitted_qc>October 30, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 6, 2013</study_first_posted>
  <results_first_submitted>March 20, 2018</results_first_submitted>
  <results_first_submitted_qc>January 10, 2019</results_first_submitted_qc>
  <results_first_posted type="Actual">January 11, 2019</results_first_posted>
  <last_update_submitted>January 10, 2019</last_update_submitted>
  <last_update_submitted_qc>January 10, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">January 11, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Vasa Previa</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vasa Previa</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>undecided</ipd_description>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <recruitment_details>In a retrospective manner, we recruited all pregnancies complicated by vasa previa that delivery between January 1, 2000 and December 31, 2012 at nine Maternal Fetal Medicine Practices. The diagnosis of vasa previa was made either during the antenatal period by an ultrasound or at the time of delivery via clinical and/or pathologic investigation</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>Vasa Previa</title>
          <description>Women with the diagnosis of Vasa Previa made during the pregnancy or at time of delivery who delivered between January 1, 2000 and December 31, 2012.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="68"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="66"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Vasa previa not confirmed</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>Women with the diagnosis of Vasa Previa made during the pregnancy or at time of delivery who delivered between January 1, 2000 and December 31, 2012.</population>
      <group_list>
        <group group_id="B1">
          <title>Vasa Previa</title>
          <description>Women with the diagnosis of Vasa Previa made during the pregnancy or at time of delivery who delivered between January 1, 2000 and December 31, 2012.</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="68"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="68"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="68"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <description>Enrolled in the US mostly western United States</description>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="68"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Diagnostic Profile of Techniques Utilized to Screen for and Diagnose Vasa Previa During Pregnancy.</title>
        <description>The primary outcome of the study it to describe antenatal techniques utilized to screen for and diagnose vasa previa. Vasa previa is when unprotected blood vessels implanted in the membranes or sac run from the placenta across the inside of the woman's cervix. Antepartum ultrasounds were conducted according to standard of care. Here we report the count of participants who were diagnosed during routine ultrasound exam. After initial diagnosis by ultrasound, Vasa Previa's were followed up by routine ultrasounds for confirmation prior to delivery.</description>
        <time_frame>Participants will be followed from time of diagnosis of vasa previa until the baby is born, an expected time frame of 9 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Vasa Previa</title>
            <description>Women with the diagnosis of Vasa Previa made during the pregnancy or at time of delivery who delivered between January 1, 2000 and December 31, 2012.</description>
          </group>
        </group_list>
        <measure>
          <title>Diagnostic Profile of Techniques Utilized to Screen for and Diagnose Vasa Previa During Pregnancy.</title>
          <description>The primary outcome of the study it to describe antenatal techniques utilized to screen for and diagnose vasa previa. Vasa previa is when unprotected blood vessels implanted in the membranes or sac run from the placenta across the inside of the woman's cervix. Antepartum ultrasounds were conducted according to standard of care. Here we report the count of participants who were diagnosed during routine ultrasound exam. After initial diagnosis by ultrasound, Vasa Previa's were followed up by routine ultrasounds for confirmation prior to delivery.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="66"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Antepartum Ultrasound, confirmed at delivery</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="47"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Antepartum Ultrasound, not confirmed at delivery</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Antepartum Ultrasound, resolved prior to delivery</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>No antepartum diagnosis, Vasa Previa at birth</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Gestational Age at Time of Diagnosis Stratified by Diagnostic Profile.</title>
        <time_frame>Participants will be followed from time of diagnosis of vasa previa during the second trimester up until delivery.</time_frame>
        <population>Only 64 participants had vasa previa diagnosed via ultrasound during the antenatal period.</population>
        <group_list>
          <group group_id="O1">
            <title>Vasa Previa</title>
            <description>Women with the diagnosis of Vasa Previa made during the pregnancy or at time of delivery who delivered between January 1, 2000 and December 31, 2012.</description>
          </group>
        </group_list>
        <measure>
          <title>Gestational Age at Time of Diagnosis Stratified by Diagnostic Profile.</title>
          <population>Only 64 participants had vasa previa diagnosed via ultrasound during the antenatal period.</population>
          <units>weeks</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="64"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Antepartum Ultrasound, confirmed at delivery</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="47"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="27.0" lower_limit="16" upper_limit="40"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Antepartum Ultrasound, not confirmed at delivery</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="27.8" lower_limit="16" upper_limit="32"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Antepartum Ultrasound, resolved prior to delivery</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="4"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="19.8" lower_limit="18" upper_limit="21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Mode of Delivery Stratified by Diagnostic Profile.</title>
        <description>Mode of delivery (C/S - emergent, non-emergent, vaginal) stratified by diagnostic profile</description>
        <time_frame>At birth.</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Emergent Cesarean Section</title>
            <description>Cesarean Section prompted by a medical emergency.</description>
          </group>
          <group group_id="O2">
            <title>Non-Emergent Cesarean Section</title>
            <description>Cesarean Section planned or non-emergency related.</description>
          </group>
          <group group_id="O3">
            <title>Vaginal Delivery</title>
            <description>Delivered vaginally.</description>
          </group>
        </group_list>
        <measure>
          <title>Mode of Delivery Stratified by Diagnostic Profile.</title>
          <description>Mode of delivery (C/S - emergent, non-emergent, vaginal) stratified by diagnostic profile</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
                <count group_id="O2" value="51"/>
                <count group_id="O3" value="5"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Antepartum Ultrasound, confirmed at delivery</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7"/>
                    <measurement group_id="O2" value="40"/>
                    <measurement group_id="O3" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Antepartum Ultrasound, not confirmed at delivery</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="9"/>
                    <measurement group_id="O3" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Antepartum Ultrasound, resolved prior to delivery</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>No antepartum diagnosis, Vasa Previa at birth</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Gestational Age of Infant at Birth</title>
        <description>Gestational age of the infant noted in weeks at the time of birth</description>
        <time_frame>At birth.</time_frame>
        <population>Mean Gestational age at delivery as well as Mean Gestational Age for those patients who delivered emergently and non-emergent are presented.</population>
        <group_list>
          <group group_id="O1">
            <title>Emergent Cesarean Section</title>
            <description>Cesarean Section prompted by a medical emergency.</description>
          </group>
          <group group_id="O2">
            <title>Non-Emergent Cesarean Section and Vaginal Delivery</title>
            <description>Cesarean Section planned or non-emergency related and Vaginal Deliveries were included in this data</description>
          </group>
        </group_list>
        <measure>
          <title>Gestational Age of Infant at Birth</title>
          <description>Gestational age of the infant noted in weeks at the time of birth</description>
          <population>Mean Gestational age at delivery as well as Mean Gestational Age for those patients who delivered emergently and non-emergent are presented.</population>
          <units>weeks</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
                <count group_id="O2" value="56"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Antepartum Ultrasound, confirmed at delivery</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="7"/>
                    <count group_id="O2" value="40"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="34.76" spread="1.24"/>
                    <measurement group_id="O2" value="34.68" spread="1.84"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Antepartum Ultrasound, not confirmed at delivery</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="2"/>
                    <count group_id="O2" value="11"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="31.50" spread="2.73"/>
                    <measurement group_id="O2" value="34.78" spread="1.47"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Antepartum Ultrasound, resolved prior to delivery</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="4"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O2" value="37.04" spread="1.55"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>No antepartum diagnosis, Vasa Previa at birth</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="36.14" spread="1"/>
                    <measurement group_id="O2" value="35.57" spread="0.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Not applicable to this retrospective study. All-Cause Mortality, Serious, and Other (Not Including Serious) Adverse Events were not monitored/assessed</time_frame>
      <desc>Not applicable to this retrospective study. All-Cause Mortality, Serious, and Other (Not Including Serious) Adverse Events were not monitored/assessed</desc>
      <group_list>
        <group group_id="E1">
          <title>Vasa Previa</title>
          <description>Women with the diagnosis of Vasa Previa made during the pregnancy or at time of delivery who delivered between January 1, 2000 and December 31, 2012.
All-Cause Mortality, Serious, and Other (Not Including Serious) Adverse Events were not monitored/assessed</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="0"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Kimberly Maurel</name_or_title>
      <organization>Mednax. Inc</organization>
      <phone>714593-9171</phone>
      <email>kimberly_maurel@mednax.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

